Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3-(di-2-thienylmethylene)-5-methyl-trans-quinolizidinium Bromide
2. Hsr 902
3. Hsr-902
4. Thiaton
1. 71731-58-3
2. Thiaton
3. Tiquizii Bromidum
4. Bromuro De Tiquizio
5. Hsr-902
6. Bromure De Tiquizium
7. 3-(di-2-thienylmethylene)-5-methyl-trans-quinolizidinium Bromide
8. 659k6049sf
9. 3-(di(2-thienyl)methylene)-5-methyldecahydroquinolizinium Bromide
10. Trans-3-(di-2-thienylmethylene)octahydro-5-methyl-2h-quinolizinium Bromide
11. (5r,9ar)-7-(dithiophen-2-ylmethylidene)-5-methyl-1,2,3,4,6,8,9,9a-octahydroquinolizin-5-ium;bromide
12. Gastirol
13. 2h-quinolizinium, 3-(di-2-thienylmethylene)octahydro-5-methyl-,bromide, (5r,9ar)-rel-
14. Advaston
15. Breiful
16. Thiameron
17. Tiapaston
18. Aspora
19. Thiwan
20. Tiquizium Bromide [inn:jan]
21. Tiquizii Bromidum [inn-latin]
22. Unii-659k6049sf
23. Hsr 902
24. Bromure De Tiquizium [inn-french]
25. Bromuro De Tiquizio [inn-spanish]
26. Thiaton (tn)
27. Ncgc00167984-01
28. Dithienylmethylene Methyl Trans-quinolizidinium
29. Dsstox_cid_26757
30. Dsstox_rid_81881
31. Dsstox_gsid_46757
32. Schembl24151
33. Mls006010103
34. Tiquizium Bromide (jan/inn)
35. Tiquizium Bromide [mi]
36. Tiquizium Bromide [inn]
37. Tiquizium Bromide [jan]
38. Chembl2360047
39. Dtxsid2046757
40. Chebi:32232
41. Tiquizium Bromide [mart.]
42. Tiquizium Bromide [who-dd]
43. Tox21_112604
44. Akos025311222
45. Smr004701242
46. Cas-71731-58-3
47. D01875
48. Q27263861
49. (5r)-3-(dithiophen-2-ylmethylene)-5-methyldecahydroquinolizinium Bromide
50. (+/-)-trans-3-(di-2-thienylmethylene)octahydro-5-methyl-2h-quinolizinium Bromide
51. (5r,9ar)-3-[di(thiophen-2-yl)methylidene]-5-methyloctahydro-2h-quinolizin-5-ium Bromide
52. (5r,9ar)-3-[di(thiophen-2-yl)methylidene]-5-methyloctahydro-2h-quinolizinium Bromide
53. Quinolizinium, Decahydro-3-(di(2-thienyl)methylene)-5-methyl-, Bromide, (e)-
Molecular Weight | 410.4 g/mol |
---|---|
Molecular Formula | C19H24BrNS2 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 2 |
Exact Mass | 409.05335 g/mol |
Monoisotopic Mass | 409.05335 g/mol |
Topological Polar Surface Area | 56.5 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 429 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A Tiquizium Bromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tiquizium Bromide, including repackagers and relabelers. The FDA regulates Tiquizium Bromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tiquizium Bromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tiquizium Bromide supplier is an individual or a company that provides Tiquizium Bromide active pharmaceutical ingredient (API) or Tiquizium Bromide finished formulations upon request. The Tiquizium Bromide suppliers may include Tiquizium Bromide API manufacturers, exporters, distributors and traders.
click here to find a list of Tiquizium Bromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Tiquizium Bromide Drug Master File in Japan (Tiquizium Bromide JDMF) empowers Tiquizium Bromide API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Tiquizium Bromide JDMF during the approval evaluation for pharmaceutical products. At the time of Tiquizium Bromide JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Tiquizium Bromide suppliers with JDMF on PharmaCompass.
Tiquizium Bromide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tiquizium Bromide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tiquizium Bromide GMP manufacturer or Tiquizium Bromide GMP API supplier for your needs.
A Tiquizium Bromide CoA (Certificate of Analysis) is a formal document that attests to Tiquizium Bromide's compliance with Tiquizium Bromide specifications and serves as a tool for batch-level quality control.
Tiquizium Bromide CoA mostly includes findings from lab analyses of a specific batch. For each Tiquizium Bromide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tiquizium Bromide may be tested according to a variety of international standards, such as European Pharmacopoeia (Tiquizium Bromide EP), Tiquizium Bromide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tiquizium Bromide USP).
LOOKING FOR A SUPPLIER?